GB2030567B - Bromo 9,10 dihydroergosine - Google Patents

Bromo 9,10 dihydroergosine

Info

Publication number
GB2030567B
GB2030567B GB7930602A GB7930602A GB2030567B GB 2030567 B GB2030567 B GB 2030567B GB 7930602 A GB7930602 A GB 7930602A GB 7930602 A GB7930602 A GB 7930602A GB 2030567 B GB2030567 B GB 2030567B
Authority
GB
United Kingdom
Prior art keywords
dihydroergosine
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB7930602A
Other versions
GB2030567A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lek Pharmaceuticals dd
Original Assignee
Lek Pharmaceuticals and Chemical Co dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Pharmaceuticals and Chemical Co dd filed Critical Lek Pharmaceuticals and Chemical Co dd
Publication of GB2030567A publication Critical patent/GB2030567A/en
Application granted granted Critical
Publication of GB2030567B publication Critical patent/GB2030567B/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB7930602A 1978-09-04 1979-09-04 Bromo 9,10 dihydroergosine Expired GB2030567B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
YU2097/78A YU40046B (en) 1978-09-04 1978-09-04 Process for preparing 2-bromo-9,10-dihydroergosine

Publications (2)

Publication Number Publication Date
GB2030567A GB2030567A (en) 1980-04-10
GB2030567B true GB2030567B (en) 1982-12-08

Family

ID=25556834

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7930602A Expired GB2030567B (en) 1978-09-04 1979-09-04 Bromo 9,10 dihydroergosine

Country Status (6)

Country Link
JP (1) JPS5535094A (en)
CH (1) CH640533A5 (en)
DE (1) DE2935685C2 (en)
FR (1) FR2434813B3 (en)
GB (1) GB2030567B (en)
YU (1) YU40046B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH649300A5 (en) * 1981-08-07 1985-05-15 Sandoz Ag ERGOPEPTIN DERIVATIVES, THEIR PRODUCTION AND USE.
DE3340025C2 (en) * 1983-11-03 1986-01-09 Schering AG, 1000 Berlin und 4709 Bergkamen Process for the preparation of 2-bromo-8-ergolinyl compounds
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
JPS5535094A (en) 1980-03-11
DE2935685A1 (en) 1980-03-06
JPS5623996B2 (en) 1981-06-03
FR2434813A1 (en) 1980-03-28
DE2935685C2 (en) 1982-12-09
GB2030567A (en) 1980-04-10
YU40046B (en) 1985-06-30
FR2434813B3 (en) 1982-02-19
CH640533A5 (en) 1984-01-13
YU209778A (en) 1983-02-28

Similar Documents

Publication Publication Date Title
GB2035303B (en) 2,3-dicyano-hydroquinone derivatives
PH14620A (en) Anti-inflammatory 4,5-diaryl-2-nitrodimidazoles
CS254979A2 (en) Zpusob vyroby 2 pyridylmethylsulfinylbenzimidazolu
CS222779A2 (en) Zpusob pripravy n heterocyklyl 4 piperidinaminu
IL60491A0 (en) 2,2-difluoro-6a-carba-pgi2 compounds
IL57923A (en) 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
ZA796336B (en) 1,2,4,5-tetra-alkyl-4-arylpiperidines
GB2022577B (en) 1,3-diary-2-imino-imidazolidines or hexahydropyrimides
GB2027030B (en) 14,15-methylene-estra-1,3,5(10)-trienes
GB2034704B (en) 2,6-daiminonebularines
GB2017093B (en) 3,3-dichloro-2-azetidinone derivatives
GB2037752B (en) 2,5-inter-o-phenylene-3,4-dinor-pgf and pgi compounds
PH14741A (en) 3,5-dihalogeno-1,2-methylenedioxybenzene
IL56443A0 (en) 2,6-dinitrobenzeneamines
GB2087873B (en) 1,2-dioximes
GB2021108B (en) 6,7 - di - 4 - amino - 2 - quinazolines
PH17142A (en) 6,7-benzomorphans
GB2018769B (en) 2,3-dihydro-4h-1-benzopyran-4-one o-carbamoyl-oximes
GB2030567B (en) Bromo 9,10 dihydroergosine
GB2032431B (en) 2,3 - dimethyl - pent - 4en - aldehyde
ZA792095B (en) 2,6-dialkyl-trifluoromethane-sulphonanilides
GB2072677B (en) 1-n-substituted 3',4'-didehydrokanamycin b derivatives
GB2013678B (en) 1,4 benzoazine derivatives
IL57189A0 (en) -(1,3-dithiolan-2-imino) substituted acetid acids
CS361079A2 (en) Hnaci jednotka, zvlaste pro visuty retezovy dopravnik

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee